Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Breast 1

Conditions

Sarcoma 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 13Ifosfamide 12Doxorubicin 12Blood Specimen Collection 12Radiotherapy 11Methotrexate 10fludarabine phosphate 9Surgical Procedures, Operative 9Radiosurgery 9Cyclophosphamide 9Surveys and Questionnaires 8Cyclosporine 8Proton Therapy 7Peripheral Blood Stem Cell Transplantation 7Busulfan 7Mycophenolic Acid 6Melphalan 6Whole-Body Irradiation 5Standard of Care 5Filgrastim 5Etoposide 5Early Intervention, Educational 5Carboplatin 5Biopsy 5Antilymphocyte Serum 5Vincristine 4Temozolomide 4Sunitinib 4Radiation Dose Hypofractionation 4Mesna 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × perifosine × Sarcoma × Clear all
NCT00847366 2018-03-15

Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma

AEterna Zentaris

Phase NA Completed
10 enrolled
BreastSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡